Compare $OM vs $RTGN | Chartloom

Compare

$OM vs $RTGN

Outset Medical Inc · RetinalGenix Technologies Inc

Outset Medical Inc

RTGN

RetinalGenix Technologies Inc

Compare $OM vs $RTGN

Comparing Outset Medical Inc and RetinalGenix Technologies Inc

OMOutset Medical Inc

RTGNRetinalGenix Technologies Inc

OMOutset Medical Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.56x

Rev growth (TTM)

-1.3%

YTD performance

9.5%

52W performance

-74.4%

FCF yield

-51.8%

RTGNRetinalGenix Technologies Inc

Market cap

$75M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-100.0%

52W performance

-100.0%

FCF yield

-0.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RTGN

Detailed metrics comparison

Outset Medical Inc

RTGN

RetinalGenix Technologies Inc

Market Cap

OM$75M

RTGN$75M

Enterprise Value

OM$138M

RTGN$75M

Price

OM$4.05

RTGN$0.00

P/E Ratio

OMN/A

RTGNN/A

P/S Ratio

OM0.64x

RTGN0.00x

EV/Sales

OM1.17x

RTGN0.00x

EV/EBITDA

OM0.00x

RTGN0.00x

P/B Ratio

OM0.77x

RTGNN/A

P/FCF Ratio

OMN/A

RTGNN/A

EV/FCF

OM-3.56x

RTGN-157.37x

PEG Ratio

OMN/A

RTGNN/A

Forward P/E (NTM)

OMN/A

RTGNN/A

Forward P/S (NTM)

OM0.56x

RTGNN/A

Revenue (TTM)

OM$118M

RTGN$0

Revenue Growth (YoY)

OM-1.3%

RTGNN/A

Forward Rev Growth

OM10.5%

RTGN0.0%

Gross Margin (TTM)

OM41.8%

RTGN0.0%

Operating Margin (TTM)

OM0.0%

RTGN0.0%

EBITDA Margin (TTM)

OM-53.2%

RTGN0.0%

Net Margin (TTM)

OM-63.1%

RTGN0.0%

FCF Margin (TTM)

OM-33.0%

RTGNN/A

Net Income (TTM)

OM$-74M

RTGN$-2M

FCF (TTM)

OM$-39M

RTGN$-478K

EPS (TTM)

OM-$3.99

RTGN-$0.11

ROE (TTM)

OM-6225.0%

RTGN-37602230.0%

ROA (TTM)

OM-2875.0%

RTGN-1265210.0%

ROIC (TTM)

OM-3438.0%

RTGN0.0%

Cash

OM$35M

RTGN$27K

Debt

OM$98M

RTGN$49K

Net Cash/Debt

OM$-63M

RTGN$-22K

Current Ratio (TTM)

OM5.19x

RTGN0.01x

Quick Ratio (TTM)

OM4.02x

RTGN0.01x

Debt/Equity (TTM)

OM1.02x

RTGN0.00x

Debt/Assets (TTM)

OM0.0%

RTGN0.0%

Interest Coverage (TTM)

OMN/A

RTGNN/A

Net Debt/EBITDA (TTM)

OM0.00x

RTGN0.00x

Beta

OM2.01

RTGN2.32

52W Performance

OM-74.4%

RTGN-100.0%

YTD Performance

OM9.5%

RTGN-100.0%

% from 52W High

OM-74.9%

RTGN-100.0%

% from 52W Low

OM42.6%

RTGNN/A

Asset Turnover (TTM)

OM0.46x

RTGN0.00x

FCF Yield (TTM)

OM-51.8%

RTGN-0.6%

Earnings Yield (TTM)

OM-98.9%

RTGN-2.8%

Dividend Yield (TTM)

OMN/A

RTGNN/A

Rule of 40

OM-34.3

RTGN0.0

EV/GP/RG

OM0.04

RTGNN/A

Ticker research

View OM research View RTGN research

Metric	OM Outset Medical Inc	RTGN RetinalGenix Technologies Inc
Market & Valuation
Market Cap	$75M	$75M
Enterprise Value	$138M	$75M
Price	$4.05	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	0.64x	0.00x
EV/Sales	1.17x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.77x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-3.56x	-157.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.56x	N/A
Revenue & Growth
Revenue (TTM)	$118M	$0
Revenue Growth (YoY)	-1.3%	N/A
Forward Rev Growth	10.5%	0.0%
Profitability
Gross Margin (TTM)	41.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-53.2%	0.0%
Net Margin (TTM)	-63.1%	0.0%
FCF Margin (TTM)	-33.0%	N/A
Net Income (TTM)	$-74M	$-2M
FCF (TTM)	$-39M	$-478K
EPS (TTM)	-$3.99	-$0.11
ROE (TTM)	-6225.0%	-37602230.0%
ROA (TTM)	-2875.0%	-1265210.0%
ROIC (TTM)	-3438.0%	0.0%
Financial Health
Cash	$35M	$27K
Debt	$98M	$49K
Net Cash/Debt	$-63M	$-22K
Current Ratio (TTM)	5.19x	0.01x
Quick Ratio (TTM)	4.02x	0.01x
Debt/Equity (TTM)	1.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.01	2.32
52W Performance	-74.4%	-100.0%
YTD Performance	9.5%	-100.0%
% from 52W High	-74.9%	-100.0%
% from 52W Low	42.6%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.46x	0.00x
FCF Yield (TTM)	-51.8%	-0.6%
Earnings Yield (TTM)	-98.9%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-34.3	0.0
EV/GP/RG	0.04	N/A
Ticker research	View OM research	View RTGN research

Valuation

P/S Ratio

RTGN

0.00x

0.64x

EV/FCF

RTGN

-157.37x

-3.56x

Growth & revenue

Revenue Growth TTM

-1.3%

Forward Revenue Growth

10.5%

RTGN

0.0%

Profitability & performance

Gross Margin

41.8%

RTGN

0.0%

ROE

-6225.0%

RTGN

-37602230.0%

FCF Yield %

RTGN

-0.6%

-51.8%

52-Week Performance

-74.4%

RTGN

-100.0%

Detailed metrics comparison

Outset Medical Inc

RTGN

RetinalGenix Technologies Inc

Market Cap

OM$75M

RTGN$75M

Enterprise Value

OM$138M

RTGN$75M

Price

OM$4.05

RTGN$0.00

P/E Ratio

OMN/A

RTGNN/A

P/S Ratio

OM0.64x

RTGN0.00x

EV/Sales

OM1.17x

RTGN0.00x

EV/EBITDA

OM0.00x

RTGN0.00x

P/B Ratio

OM0.77x

RTGNN/A

P/FCF Ratio

OMN/A

RTGNN/A

EV/FCF

OM-3.56x

RTGN-157.37x

PEG Ratio

OMN/A

RTGNN/A

Forward P/E (NTM)

OMN/A

RTGNN/A

Forward P/S (NTM)

OM0.56x

RTGNN/A

Revenue (TTM)

OM$118M

RTGN$0

Revenue Growth (YoY)

OM-1.3%

RTGNN/A

Forward Rev Growth

OM10.5%

RTGN0.0%

Gross Margin (TTM)

OM41.8%

RTGN0.0%

Operating Margin (TTM)

OM0.0%

RTGN0.0%

EBITDA Margin (TTM)

OM-53.2%

RTGN0.0%

Net Margin (TTM)

OM-63.1%

RTGN0.0%

FCF Margin (TTM)

OM-33.0%

RTGNN/A

Net Income (TTM)

OM$-74M

RTGN$-2M

FCF (TTM)

OM$-39M

RTGN$-478K

EPS (TTM)

OM-$3.99

RTGN-$0.11

ROE (TTM)

OM-6225.0%

RTGN-37602230.0%

ROA (TTM)

OM-2875.0%

RTGN-1265210.0%

ROIC (TTM)

OM-3438.0%

RTGN0.0%

Cash

OM$35M

RTGN$27K

Debt

OM$98M

RTGN$49K

Net Cash/Debt

OM$-63M

RTGN$-22K

Current Ratio (TTM)

OM5.19x

RTGN0.01x

Quick Ratio (TTM)

OM4.02x

RTGN0.01x

Debt/Equity (TTM)

OM1.02x

RTGN0.00x

Debt/Assets (TTM)

OM0.0%

RTGN0.0%

Interest Coverage (TTM)

OMN/A

RTGNN/A

Net Debt/EBITDA (TTM)

OM0.00x

RTGN0.00x

Beta

OM2.01

RTGN2.32

52W Performance

OM-74.4%

RTGN-100.0%

YTD Performance

OM9.5%

RTGN-100.0%

% from 52W High

OM-74.9%

RTGN-100.0%

% from 52W Low

OM42.6%

RTGNN/A

Asset Turnover (TTM)

OM0.46x

RTGN0.00x

FCF Yield (TTM)

OM-51.8%

RTGN-0.6%

Earnings Yield (TTM)

OM-98.9%

RTGN-2.8%

Dividend Yield (TTM)

OMN/A

RTGNN/A

Rule of 40

OM-34.3

RTGN0.0

EV/GP/RG

OM0.04

RTGNN/A

Ticker research

View OM research View RTGN research

Metric	OM Outset Medical Inc	RTGN RetinalGenix Technologies Inc
Market & Valuation
Market Cap	$75M	$75M
Enterprise Value	$138M	$75M
Price	$4.05	$0.00
P/E Ratio	N/A	N/A
P/S Ratio	0.64x	0.00x
EV/Sales	1.17x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.77x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-3.56x	-157.37x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	0.56x	N/A
Revenue & Growth
Revenue (TTM)	$118M	$0
Revenue Growth (YoY)	-1.3%	N/A
Forward Rev Growth	10.5%	0.0%
Profitability
Gross Margin (TTM)	41.8%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-53.2%	0.0%
Net Margin (TTM)	-63.1%	0.0%
FCF Margin (TTM)	-33.0%	N/A
Net Income (TTM)	$-74M	$-2M
FCF (TTM)	$-39M	$-478K
EPS (TTM)	-$3.99	-$0.11
ROE (TTM)	-6225.0%	-37602230.0%
ROA (TTM)	-2875.0%	-1265210.0%
ROIC (TTM)	-3438.0%	0.0%
Financial Health
Cash	$35M	$27K
Debt	$98M	$49K
Net Cash/Debt	$-63M	$-22K
Current Ratio (TTM)	5.19x	0.01x
Quick Ratio (TTM)	4.02x	0.01x
Debt/Equity (TTM)	1.02x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.01	2.32
52W Performance	-74.4%	-100.0%
YTD Performance	9.5%	-100.0%
% from 52W High	-74.9%	-100.0%
% from 52W Low	42.6%	N/A
Efficiency & Yields
Asset Turnover (TTM)	0.46x	0.00x
FCF Yield (TTM)	-51.8%	-0.6%
Earnings Yield (TTM)	-98.9%	-2.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-34.3	0.0
EV/GP/RG	0.04	N/A
Ticker research	View OM research	View RTGN research